| 1. |
- Arvhult, Carl-Magnus, et al.
(författare)
-
Experimental Phase Diagram Study of the Fe-Ni-Te System
- 2019
-
Ingår i: JOURNAL OF PHASE EQUILIBRIA AND DIFFUSION. - : Springer Nature. - 1547-7037 .- 1863-7345. ; 40:4, s. 610-622
-
Tidskriftsartikel (refereegranskat)abstract
- Fe-Ni-Te alloys have been experimentally studied using isothermal heat treatments with SEM-EDS and WDS, XRD, and DTA in order to add phase diagram data for a thermodynamic assessment. This is for the application of fission product-induced corrosion of the stainless steel cladding of nuclear fuel pins, where Te is a key element. Phase diagram data are presented at phase. SEM images show unidentified precipitates in several samples.
|
|
| 2. |
- Arvhult, Carl, et al.
(författare)
-
Thermodynamic assessment of the Ni-Te system
- 2019
-
Ingår i: Journal of Materials Science. - : SPRINGER. - 0022-2461 .- 1573-4803. ; 54:16, s. 11304-11319
-
Tidskriftsartikel (refereegranskat)abstract
- A thermodynamic assessment of the Ni-Te system has been performed using the Calphad method, based on experimental data available in the literature. The proposed description has been developed for use in the modeling of fission-product-induced internal corrosion of stainless steel cladding in Generation IV nuclear reactors. DFT calculations were performed to obtain 0 K properties of solid phases to assist the thermodynamic optimization. The ionic liquid two-sublattice model was used, and most solution phases were modeled using interstitial metal sub-lattices. With a strict number of parameters, the resulting description satisfactorily reproduces all thermodynamic properties and high-temperature phase transitions. The metastable miscibility gap in the Ni-rich liquid that is experimentally suggested is not present in the final description. The phase exhibits a metastable order-disorder transition between the CdI2 and NiAs types of interstitial nickel distribution. The CdI2 prototype is the stable space group at room temperature. Low-temperature ordering phase transitions have been disregarded in this description, since they are not of interest to the application of corrosion in nuclear reactors.
|
|
| 3. |
- Journeau, Christophe, et al.
(författare)
-
SAFEST ROADMAP FOR CORIUM EXPERIMENTAL RESEARCH IN EUROPE
- 2016
-
Ingår i: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON NUCLEAR ENGINEERING, 2016, VOL 4. - : ASME Press. - 9780791850046
-
Konferensbidrag (refereegranskat)abstract
- SAFEST (Severe Accident Facilities for European Safety Targets) is a European project networking the European corium experimental laboratories with the objective to establish coordination activities, enabling the development of a common vision and research roadmaps for the next years, and of the management structure to achieve these goals. In this frame, a European roadmap on corium experimental research has been written to define research challenges to contribute to further reinforcement of Gen II and III NPP safety. It is based on the research priorities deteimined by SARNET SARP group as well as those from the recently formulated in the NUGENIA Roadmap for severe accidents and the recently published NUGENIA Global Vision report. It also takes into account issues identified in the analysis of the European stress tests and from the interpretation of the Fukushima accident. 19 relevant issues related to corium have been selected during these prioritization efforts. These issues have been compared to a survey of the European corium experimental facilities and corium analysis laboratories. Finally, the coherence between European infrastructures and R&D needs has been assessed and a table linking issues and infrastructures has been derived. It shows a few lacks in EU corium infrastructures, especially in the domains of core late reflooding impact on source term, Reactor Pressure Vessel failure and corium release, Spent Fuel Pool accidents, as well as the need for a large mass (100500 kg) prototypic corium facility.
|
|
| 4. |
- Krege, Susanne, et al.
(författare)
-
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part I
- 2008
-
Ingår i: European Urology. - : Elsevier BV. - 1873-7560 .- 0302-2838. ; 53:3, s. 478-496
-
Forskningsöversikt (refereegranskat)abstract
- Objectives: The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, Amsterdam, The Netherlands. Methods: Medical oncologists, urological surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference, and incorporated the new data into updated and revised guidelines. As for the first meeting, the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. Results: The first part of the consensus paper describes the clinical presentation of the primary tumor, its treatment, the importance and treatment of testicular intraepithelial neoplasia (TIN), histological classification, staging and prognostic factors, and treatment of stage I seminoma and non-seminoma. Conclusions: Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early- and advanced-stage testicular cancer have emerged from clinical trials. Despite technical improvements, expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer. In addition, the particular needs of testicular cancer survivors have been acknowledged. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
|
| 5. |
- Krege, Susanne, et al.
(författare)
-
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
- 2008
-
Ingår i: European Urology. - : Elsevier BV. - 1873-7560 .- 0302-2838. ; 53:3, s. 497-513
-
Forskningsöversikt (refereegranskat)abstract
- Objectives: The first consensus report that had been presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, The Netherlands. Methods: Medical oncologists, urologic surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference and incorporated the new data into updated and revised guidelines. As for the first meeting the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. Results: The second part of the consensus paper includes the treatment of metastasised disease, residual tumour resection, salvage therapy, follow-up, and late toxicities. Conclusions: Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early-stage as well as of advanced-stage testicular cancer have emerged from clinical trials. Despite technical improvements, expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer. in addition, the particular needs of testicular cancer survivors have been acknowledged. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
|
